The estimated Net Worth of Kyle Detwiler is at least $329 ezer dollars as of 30 December 2021. Mr Detwiler owns over 46,390 units of Clever Leaves stock worth over $421 and over the last 4 years he sold CLVR stock worth over $148,448. In addition, he makes $179,890 as CEO & Chairman at Clever Leaves.
Mr has made over 1 trades of the Clever Leaves stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 46,390 units of CLVR stock worth $148,448 on 30 December 2021.
The largest trade he's ever made was selling 46,390 units of Clever Leaves stock on 30 December 2021 worth over $148,448. On average, Mr trades about 9,278 units every 0 days since 2021. As of 30 December 2021 he still owns at least 2,106,381 units of Clever Leaves stock.
You can see the complete history of Mr Detwiler stock trades at the bottom of the page.
Kyle Detwiler is the CEO & Chairman at Clever Leaves.
As the CEO & Chairman of Clever Leaves, the total compensation of Mr Detwiler at Clever Leaves is $179,890. There are 3 executives at Clever Leaves getting paid more, with Andres Fajardo having the highest compensation of $303,078.
Mr Detwiler is 38, he's been the CEO & Chairman of Clever Leaves since . There are 5 older and no younger executives at Clever Leaves. The oldest executive at Clever Leaves Holdings Inc. is David M. Kastin Esq., 53, who is the Gen. Counsel & Corp. Sec..
Kyle's mailing address filed with the SEC is 6501 CONGRESS AVE, , BOCA RATON, FL, 33487.
Over the last 4 years, insiders at Clever Leaves have traded over $235,856 worth of Clever Leaves stock. The most active insiders traders include Elisabeth H Demarse, Andres Fajardo és Kyle Detwiler. On average, Clever Leaves executives and independent directors trade stock every 29 days with the average trade being worth of $1. The most recent stock trade was executed by Henry R Iii Hague on 8 March 2024, trading 170 units of CLVR stock currently worth $563.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Clever Leaves executives and other stock owners filed with the SEC include: